TELA Bio, Inc. (TELA)
TELA Stock Price Chart
Explore TELA Bio, Inc. interactive price chart. Choose custom timeframes to analyze TELA price movements and trends.
TELA Company Profile
Discover essential business fundamentals and corporate details for TELA Bio, Inc. (TELA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
8 Nov 2019
Employees
209.00
Website
https://www.telabio.comCEO
Antony Koblish
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
TELA Financial Timeline
Browse a chronological timeline of TELA Bio, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.17, while revenue estimate is $21.78M.
Earnings released on 11 Aug 2025
EPS came in at -$0.22 falling short of the estimated -$0.18 by -22.22%, while revenue for the quarter reached $20.20M , missing expectations by -8.79%.
Earnings released on 8 May 2025
EPS came in at -$0.25 falling short of the estimated -$0.21 by -19.05%, while revenue for the quarter reached $18.52M , beating expectations by +6.73%.
Earnings released on 20 Mar 2025
EPS came in at -$0.23 surpassing the estimated -$0.24 by +4.17%, while revenue for the quarter reached $17.65M , missing expectations by -16.15%.
Earnings released on 7 Nov 2024
EPS came in at -$0.42 falling short of the estimated -$0.37 by -13.51%, while revenue for the quarter reached $18.96M , missing expectations by -18.17%.
Earnings released on 12 Aug 2024
EPS came in at -$0.51 falling short of the estimated -$0.45 by -13.33%, while revenue for the quarter reached $16.09M , missing expectations by -12.83%.
Earnings released on 9 May 2024
EPS came in at -$0.23 surpassing the estimated -$0.48 by +52.08%, while revenue for the quarter reached $16.60M , beating expectations by +1.73%.
Earnings released on 21 Mar 2024
EPS came in at -$0.53 falling short of the estimated -$0.44 by -20.45%, while revenue for the quarter reached $17.00M , beating expectations by +3.71%.
Earnings released on 9 Nov 2023
EPS came in at -$0.45 surpassing the estimated -$0.52 by +13.46%, while revenue for the quarter reached $15.05M , missing expectations by -8.16%.
Earnings released on 9 Aug 2023
EPS came in at -$0.46 surpassing the estimated -$0.58 by +20.69%, while revenue for the quarter reached $14.49M , beating expectations by +0.65%.
Earnings released on 11 May 2023
EPS came in at -$0.63 falling short of the estimated -$0.51 by -23.53%, while revenue for the quarter reached $11.91M , missing expectations by -0.92%.
Earnings released on 21 Mar 2023
EPS came in at -$0.52 surpassing the estimated -$0.58 by +10.34%, while revenue for the quarter reached $11.62M , missing expectations by -11.89%.
Earnings released on 9 Nov 2022
EPS came in at -$0.64 falling short of the estimated -$0.57 by -12.28%, while revenue for the quarter reached $11.16M , beating expectations by +2.74%.
Earnings released on 10 Aug 2022
EPS came in at -$0.80 falling short of the estimated -$0.60 by -33.33%, while revenue for the quarter reached $10.41M , beating expectations by +2.81%.
Earnings released on 10 May 2022
EPS came in at -$0.75 falling short of the estimated -$0.50 by -50.00%, while revenue for the quarter reached $8.23M , beating expectations by +3.62%.
Earnings released on 21 Mar 2022
EPS came in at -$0.59 falling short of the estimated -$0.54 by -9.26%, while revenue for the quarter reached $8.37M , beating expectations by +5.13%.
Earnings released on 10 Nov 2021
EPS came in at -$0.57 falling short of the estimated -$0.52 by -9.62%, while revenue for the quarter reached $7.65M , beating expectations by +10.64%.
Earnings released on 11 Aug 2021
EPS came in at -$0.57 falling short of the estimated -$0.49 by -16.33%, while revenue for the quarter reached $7.56M , beating expectations by +19.78%.
Earnings released on 13 May 2021
EPS came in at -$0.56 falling short of the estimated -$0.44 by -27.27%, while revenue for the quarter reached $5.88M , beating expectations by +7.64%.
Earnings released on 24 Mar 2021
EPS came in at -$0.54 falling short of the estimated -$0.51 by -5.88%, while revenue for the quarter reached $5.67M .
Earnings released on 11 Nov 2020
EPS came in at -$0.53 falling short of the estimated -$0.50 by -6.00%, while revenue for the quarter reached $5.31M , beating expectations by +8.89%.
TELA Stock Performance
Access detailed TELA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.